Search
- Page Path
-
HOME
> Search
Meta-Analysis
- Exploring COVID-19 Pandemic Disparities with Transcriptomic Meta-analysis from the Perspective of Personalized Medicine.
-
Medi Kori, Ceyda Kasavi, Kazim Yalcin Arga
-
J. Microbiol. 2024;62(9):785-798. Published online July 9, 2024
-
DOI: https://doi.org/10.1007/s12275-024-00154-9
-
-
Abstract
- Infection with SARS-CoV2, which is responsible for COVID-19, can lead to differences in disease development, severity and mortality rates depending on gender, age or the presence of certain diseases. Considering that existing studies ignore these differences, this study aims to uncover potential differences attributable to gender, age and source of sampling as well as viral load using bioinformatics and multi-omics approaches. Differential gene expression analyses were used to analyse the phenotypic differences between SARS-CoV-2 patients and controls at the mRNA level. Pathway enrichment analyses were performed at the gene set level to identify the activated pathways corresponding to the differences in the samples. Drug repurposing analysis was performed at the protein level, focusing on host-mediated drug candidates to uncover potential therapeutic differences. Significant differences (i.e. the number of differentially expressed genes and their characteristics) were observed for COVID-19 at the mRNA level depending on the sample source, gender and age of the samples. The results of the pathway enrichment show that SARS-CoV-2 can be combated more effectively in the respiratory tract than in the blood samples.
Taking into account the different sample sources and their characteristics, different drug candidates were identified. Evaluating disease prediction, prevention and/or treatment strategies from a personalised perspective is crucial. In this study, we not only evaluated the differences in COVID-19 from a personalised perspective, but also provided valuable data for further experimental and clinical efforts. Our findings could shed light on potential pandemics.
Journal Article
- Limiting the pathogenesis of Salmonella Typhimurium with berry phenolic extracts and linoleic acid overproducing Lactobacillus casei
-
Zajeba Tabashsum , Mengfei Peng , Cassendra Bernhardt , Puja Patel , Michael Carrion , Shaik O. Rahaman , Debabrata Biswas
-
J. Microbiol. 2020;58(6):489-498. Published online April 22, 2020
-
DOI: https://doi.org/10.1007/s12275-020-9545-1
-
-
16
View
-
0
Download
-
5
Citations
-
Abstract
- The growing threat of emergent multidrug-resistant enteric
bacterial pathogens, and their adopted virulence properties
are directing to find alternative antimicrobials and/or development
of dietaries that can improve host gut health and/or
defense. Recently, we found that modified Lactobacillus casei
(Lc + CLA) with increased production of conjugated linoleic
acid has antimicrobial and other beneficial properties.
Further, prebiotic alike products such as berry pomace extracts
(BPEs), increase the growth of probiotics and inhibit
the growth of certain bacterial pathogens. In this study, we
evaluated the antibacterial effect of genetically modified Lc +
CLA along with BPEs against major enteric pathogen Salmonella
enterica serovar Typhimurium (ST). In mixed culture
condition, the growth of ST was significantly reduced in the
presence of Lc + CLA and/or BPEs. Bacterial cell-free cultural
supernatant (CFCS) collected from wild-type Lc or modified
Lc + CLA strains also inhibited the growth and survival of ST,
and those inhibitory effects were enhanced in the presence of
BPEs. We also found that the interaction of the pathogen with
cultured host (HD-11 and INT-407) cells were also altered in
the presence of either Lc or Lc + CLA strain or their CFCSs
significantly. Furthermore, the relative expression of genes
related to ST virulence and physicochemical properties of ST
was altered by the effect of CFCSs of either Lc or Lc + CLA.
These findings indicate that a diet containing synbiotic, specifically
linoleic acid, over-produced Lc + CLA and prebiotic
product BPEs, might have the potential to be effective in controlling
ST growth and pathogenesis.
TOP